<DOC>
	<DOC>NCT00192855</DOC>
	<brief_summary>This study is testing the hypothesis that Entacapone added to ongoing antipsychotic treatment can be beneficial in schizophrenic patients with negative symptoms.</brief_summary>
	<brief_title>Entacapone Augmentation for Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<criteria>predominantly negative symptoms stable on ongoing antipsychotic treatment acute psychotic exacerbation suicidal ideation uncontrolled systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>negative symptoms</keyword>
	<keyword>entacapone</keyword>
</DOC>